Medication info
Atostatin 10 mg (Atorvastatin Calcium Trihydrate)

Atostatin 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
White oval-shaped film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200705825 · Notified 2007.05.21 · Insurance code 642702290

Summary

Main use
Improvement of hyperlipidemia (e.g., familial hypercholesterolemia in children) and prevention of cardiovascular disease (e.g., myocardial infarction)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients).

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (e.g., familial hypercholesterolemia in children) and prevention of cardiovascular disease (e.g., myocardial infarction)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • revascularization procedures
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
View approved original text

This medication helps to reduce the risk of cardiovascular diseases. Specifically, it decreases the risk of myocardial infarction and stroke in adults who are at risk for coronary heart disease or have type 2 diabetes, and lowers the risk of revascularization procedures and angina. Furthermore, in patients with existing coronary heart disease, it is effective in reducing the risk of hospitalization for myocardial infarction, stroke, angina, and congestive heart failure. In the treatment of hyperlipidemia, it is used to manage cholesterol and triglyceride levels in patients with primary and familial hypercholesterolemia, as well as mixed dyslipidemia. It also helps lower cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia when used in conjunction with dietary modifications. Therefore, this drug is effective in improving significant risk factors for cardiovascular diseases and hyperlipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients).

Precautions

This medication may cause unusual symptoms in muscles, so if severe muscle pain or weakness occurs, or if creatine kinase levels are significantly elevated, the use of this medication should be discontinued immediately. This drug should not be used in patients with certain liver or muscle diseases, women who are pregnant or could become pregnant, children under 10 years of age, and patients taking specific medications. Patients with liver or kidney function problems should be particularly cautious when taking this medication and should monitor liver function and muscle condition regularly. Side effects such as muscle pain, fatigue, malaise, indigestion, headache, and insomnia may occur while taking this medication, so if these symptoms are severe or persistent, consultation with a physician is necessary. Additionally, this medication has a high potential for interactions with other drugs, so if other medications are being taken, it is essential to inform a healthcare provider and not to discontinue or change medication regimens arbitrarily. This medication is contraindicated during pregnancy, and women of childbearing potential should use appropriate contraception while taking it, discontinuing use immediately if pregnancy is confirmed. Lactating women should not take this medication and should either discontinue breastfeeding or consult a healthcare provider. Elderly patients or those with kidney impairment have a higher risk of muscle disease and rhabdomyolysis, so caution is advised, and regular health assessments are recommended. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored periodically. Keep out of reach of children and store the medication in its original container to maintain quality.

Side effects

  • Apathy
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 160 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory decrease
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular edema
  • erythema multiforme
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • elevated serum ALT levels
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • dizziness
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • increased tension
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • urinary difficulty
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency incontinence
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypothermia
  • increased non-protein nitrogen
  • hyperlipidemia
  • facial flushing
  • sleep disorders
  • cognitive decline
  • amnestic syndrome
  • memory impairment
  • confusion
  • myasthenia gravis
  • ocular myasthenia
  • increased AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. Ideally, maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval-shaped film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.